Sort   by:  
 Page size 
ProteomicsiTRAQ analysis of K562 cell line
K562 cells untreated (S) and treated (S+IM) with Imatinib as well as sensitive (S+IM) and resistant (R) to imatinib were subjected to labelled quantification by iTRAQ to identify Bcr-Abl downstream signaling components and proteins modulated in resistance respectively
ORGANISM(S): Homo sapiens (Human) 
2021-10-05 | PXD025173 | Pride
K562 Itraq 
ProteomicsLC-MSMS of leukemic cell line K562
Comparative label free quantitative proteomic analysis using SWATH-MS has been carried out for K562 cells treated with Imatinib (S+IM) against untreated K562 (S) as well as imatinib resistant K562 cells (R). Compariosn of S+IM vs R constitutes Dataset 1 while that of S vs S+IM constitutes dataset 2
ORGANISM(S): Homo sapiens (Human) 
2019-06-14 | PXD009686 | Pride
K562 Swath-ms Lc-msms 
Sort   by:  
 Page size